the benefits of omega-3 fatty acids have been reported in the management of non-alcoholic fatty liver disease (NAFLD) complications.This study evaluated the effects of Camelina sativa oil (CSO) supplementation as one of the richest dietary sources of omega-3 fatty acids on glucose homeostasis,inflammation, metabolic endotoxemia, and oxidative stress in NAFLD patients. Camelina seed oil contains 35%–40% of α-linolenic acid (C18:3 ω3, ALA), which is an essential omega-3 fatty acid (Belayneh et al., 2015). ALA can be converted to eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA); however, the conversion of ALA to EPA and DHA is limited and affected by the level of the dietary intake of ALA and linoleic acid.